PNC Financial Services Group’s Utah Medical Products UTMD Stock Holding History

PNC Financial Services Group’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$42.9K	Buy	622 +13	+2%	+$864	﹤0.01%	3430
2026 Q1	$37.8K	Buy	609 +99	+19%	+$6.24K	﹤0.01%	3378
2025 Q4	$28.5K	Sell	510 -92	-15%	-$5.33K	﹤0.01%	3495
2025 Q3	$37.9K	Buy	602 +98	+19%	+$5.8K	﹤0.01%	3346
2025 Q2	$28.7K	Sell	504 -390	-44%	-$21.2K	﹤0.01%	3403
2025 Q1	$50.1K	Buy	894 +546	+157%	+$32.7K	﹤0.01%	3093
2024 Q4	$21.4K	Sell	348 -448	-56%	-$29K	﹤0.01%	3501
2024 Q3	$53.3K	Hold	796	–	–	﹤0.01%	3046
2024 Q2	$53.2K	Buy	796 +496	+165%	+$33.8K	﹤0.01%	2998
2024 Q1	$21.3K	Sell	300 -24	-7%	-$1.8K	﹤0.01%	3421
2023 Q4	$27.3K	Hold	324	–	–	﹤0.01%	3265
2023 Q3	$27.9K	Hold	324	–	–	﹤0.01%	3253
2023 Q2	$30.2K	Hold	324	–	–	﹤0.01%	3338
2023 Q1	$30.7K	Buy	324 +24	+8%	+$2.21K	﹤0.01%	3265
2022 Q4	$30.2K	Hold	300	–	–	﹤0.01%	3262
2022 Q3	$26K	Hold	300	–	–	﹤0.01%	3334
2022 Q2	$26K	Hold	300	–	–	﹤0.01%	3362
2022 Q1	$27K	Hold	300	–	–	﹤0.01%	3439
2021 Q4	$30K	Sell	300 -6	-2%	-$612	﹤0.01%	3375
2021 Q3	$28K	Hold	306	–	–	﹤0.01%	3372
2021 Q2	$26K	Hold	306	–	–	﹤0.01%	3366
2021 Q1	$26K	Hold	306	–	–	﹤0.01%	3313
2020 Q4	$26K	Hold	306	–	–	﹤0.01%	3229
2020 Q3	$24K	Hold	306	–	–	﹤0.01%	3144
2020 Q2	$27K	Hold	306	–	–	﹤0.01%	3076
2020 Q1	$29K	Hold	306	–	–	﹤0.01%	2931
2019 Q4	$33K	Hold	306	–	–	﹤0.01%	3124
2019 Q3	$29K	Hold	306	–	–	﹤0.01%	3202
2019 Q2	$29K	Hold	306	–	–	﹤0.01%	3203
2019 Q1	$27K	Hold	306	–	–	﹤0.01%	3240
2018 Q4	$25K	Hold	306	–	–	﹤0.01%	3216
2018 Q3	$29K	Hold	306	–	–	﹤0.01%	3290
2018 Q2	$34K	Hold	306	–	–	﹤0.01%	3229
2018 Q1	$30K	Hold	306	–	–	﹤0.01%	3236
2017 Q4	$25K	Hold	306	–	–	﹤0.01%	3300
2017 Q3	$23K	Buy	306 +6	+2%	+$432	﹤0.01%	3328
2017 Q2	$22K	Hold	300	–	–	﹤0.01%	3303
2017 Q1	$19K	Hold	300	–	–	﹤0.01%	3317
2016 Q4	$22K	Hold	300	–	–	﹤0.01%	3199
2016 Q3	$18K	Sell	300 -35	-10%	-$2.23K	﹤0.01%	3280
2016 Q2	$21K	Sell	335 -1	-0.3%	-$64	﹤0.01%	3244
2016 Q1	$21K	Buy	336 +1	+0.3%	+$59	﹤0.01%	3262
2015 Q4	$20K	Hold	335	–	–	﹤0.01%	3305
2015 Q3	$18K	Buy	335 +1	+0.3%	+$55	﹤0.01%	3430
2015 Q2	$20K	Buy	334 +15	+5%	+$844	﹤0.01%	3502
2015 Q1	$19K	Sell	319 -27	-8%	-$1.59K	﹤0.01%	3531
2014 Q4	$21K	Buy	346 +46	+15%	+$2.55K	﹤0.01%	3134
2014 Q3	$15K	Hold	300	–	–	﹤0.01%	3159
2014 Q2	$15K	Hold	300	–	–	﹤0.01%	3035
2014 Q1	$17K	Hold	300	–	–	﹤0.01%	2901
2013 Q4	$17K	Sell	300 -265	-47%	-$14.5K	﹤0.01%	2855
2013 Q3	$34K	Hold	565	–	–	﹤0.01%	2637
2013 Q2	$30K	Buy	+565	New	+$26.6K	﹤0.01%	2596

Other funds holding UTMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CCMINC

Cardinal Capital Management Inc (North Carolina) Raleigh, North Carolina $826M AUM 32.06% 1-Year Est. Return

EHC

Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

RWM

Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

PNC Financial Services Group's UTMD Position: Q2 2026 in Review

PNC Financial Services Group increased its Utah Medical Products (UTMD) stake by 2.1% in Q2 2026, buying an estimated $864 and bringing the position to 622 shares worth $42.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3430.

PNC Financial Services Group first reported a position in UTMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $53.3K in Q3 2024. 50 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

PNC Financial Services Group held 622 shares of Utah Medical Products worth $42.9K as of Q2 2026.
PNC Financial Services Group bought 13 Utah Medical Products shares in Q2 2026, an estimated $864.
Utah Medical Products made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3430 holding.
PNC Financial Services Group first reported a position in Utah Medical Products in Q2 2013 and has held it in 53 quarters since.
PNC Financial Services Group's Utah Medical Products position peaked at $53.3K in Q3 2024.
50 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.